ClinicalTrials.govpublic full text
MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer
breast neoplasms, her2/her3, bispecific antibody, breast cancer, advanced breast cancer, metastatic breast cancer, her2 positive breast cancer, trastuzumab, herceptin, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 856762
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.